The blood analysis company Cellavision will release its report for the third quarter on Thursday.
Expected EBITDA, according to Factset consensus based on estimates from four analysts, is SEK 57 million. In the corresponding period last year, the result was SEK 50 million.
The company will release the report at 07.20 and hold a conference call at 11.00.
CellavisionReport date2026-10-29(SEK million)Q3-2026, forecastNumber of estimatesPrevious yearSales1934176EBITDA57450Source: Factset
Price performance on reporting days for the latest reports as follows:
PeriodReport datePrice performance on reporting day, %Q2-20262026-07-177,8Q1-20262026-04-24-21,5Q4-20252026-02-0511,3Q3-20252025-11-06-9,1Q2-20252025-07-181,4Q1-20252025-04-2922,7Q4-20242025-02-06-7,9Q3-20242024-10-241,5
